Rijksinstituut voor Volksgezondheid en Milieu Evidence synthesis in harm assessment of medicines using the example of rosiglitazone and myocardial infarction | RIVM Jaar: 2018 Evidence synthesis in harm assessment of medicines using the example of rosiglitazone and myocardial infarction | RIVM Bron: rivm.nl Download dossier (ZIP) · JSON